scispace - formally typeset
Journal ArticleDOI

Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

Joseph T. Coyle
- 14 Jun 2006 - 
- Vol. 26, Iss: 4, pp 365-384
TLDR
Hypofunction of the NMDA receptor, possibly on critical GABAergic inter-neurons, may contribute to the pathophysiology of schizophrenia.
Abstract
1. After 50 years of antipsychotic drug development focused on the dopamine D2 receptor, schizophrenia remains a chronic, disabling disorder for most affected individuals.

read more

Citations
More filters
Journal ArticleDOI

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

TL;DR: A well-defined set of clinical characteristics are associated with anti-NMDA-receptor encephalitis and the pathogenesis of the disorder seems to be mediated by antibodies.
Journal ArticleDOI

Dendritic spine pathology in neuropsychiatric disorders

TL;DR: This work discusses recent neuropathological, genetic, molecular and animal model studies that implicate structural alterations at spiny synapses in the pathogenesis of major neurological disorders, focusing on ASD, schizophrenia and Alzheimer's disease as representatives of these categories across different ages of onset.
Journal ArticleDOI

Neurobiology of schizophrenia.

TL;DR: In this paper, the authors identify proteins of candidate genetic risk factors for schizophrenia, including dysbindin, neuregulin 1, DAOA, COMT, and DISC1.
Journal ArticleDOI

Glutamate and dopamine in schizophrenia: an update for the 21st century

TL;DR: This review provides an update on the latest findings on dopamine and glutamate abnormalities in schizophrenia, focusing on in vivo neuroimaging studies in patients and clinical high-risk groups, and considers their implications for understanding the biology and treatment of schizophrenia.
Journal ArticleDOI

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

TL;DR: It is shown that exposure of mice to ketamine induced a persistent increase in brain superoxide due to activation in neurons of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which suggests that NADPH oxidase may represent a novel target for the treatment of ketamine-induced psychosis.
References
More filters
Journal ArticleDOI

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

TL;DR: These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.
Journal ArticleDOI

Recent advances in the phencyclidine model of schizophrenia.

TL;DR: It was found that PCP-induced psychotomimetic effects are associated with submicromolar serum concentrations of PCP and the findings suggest that endogenous dysfunction of NMDA receptor-mediated neurotransmission might contribute to the pathogenesis of schizophrenia.
Journal ArticleDOI

Tripartite synapses : Glia, the unacknowledged partner

TL;DR: It is suggested that perisynaptic Schwann cells and synaptically associated astrocytes should be viewed as integral modulatory elements of tripartite synapses.
Journal ArticleDOI

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

TL;DR: This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry.
Related Papers (5)